NAV therapeutics
/ REGENXBIO
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 26, 2021
"#AnavoTherapeutics Launches with EUR 20 Million #SeedFinancing to Create Industry-Leading Pipeline of #AllostericPhosphataseModulators https://t.co/oMuyAmraps"
(@1stOncology)
1 to 1
Of
1
Go to page
1